Aristotle Atlantic Partners’s Gilead Sciences GILD Stock Holding History

Aristotle Atlantic Partners’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$505K	Hold	4,000	–	–	0.02%	104
2026 Q1	$557K	Buy	+4,000	New	+$560K	0.03%	100
2021 Q3	–	Sell	-21,200	Closed	-$1.46M	–	101
2021 Q2	$1.46M	Hold	21,200	–	–	0.1%	81
2021 Q1	$1.37M	Hold	21,200	–	–	0.1%	78
2020 Q4	$1.24M	Hold	21,200	–	–	0.1%	78
2020 Q3	$1.34M	Hold	21,200	–	–	0.12%	75
2020 Q2	$1.63M	Hold	21,200	–	–	0.16%	70
2020 Q1	$1.58M	Hold	21,200	–	–	0.24%	52
2019 Q4	$1.38M	Hold	21,200	–	–	0.18%	66
2019 Q3	$1.34M	Hold	21,200	–	–	0.39%	60
2019 Q2	$1.43M	Sell	21,200 -22,000	-51%	-$1.45M	0.42%	47
2019 Q1	$2.81M	Sell	43,200 -19,000	-31%	-$1.26M	0.85%	24
2018 Q4	$3.89M	Sell	62,200 -300	-0.5%	-$21K	1.37%	17
2018 Q3	$2.7M	Hold	62,500	–	–	1.65%	19
2018 Q2	$4.43M	Sell	62,500 -34,000	-35%	-$2.4M	1.53%	15
2018 Q1	$7.28M	Hold	96,500	–	–	2.63%	11
2017 Q4	$6.91M	Buy	+96,500	New	+$7.33M	2.48%	12

Other funds holding GILD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Aristotle Atlantic Partners's GILD Position: Q2 2026 in Review

Aristotle Atlantic Partners held its Gilead Sciences (GILD) position steady in Q2 2026 at 4,000 shares worth $505K. The position accounts for 0.02% of the portfolio, ranked #104.

Aristotle Atlantic Partners first reported a position in GILD in Q4 2017 and has held it in 17 quarters since. The position peaked at $7.28M in Q1 2018. 2,268 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

Aristotle Atlantic Partners held 4,000 shares of Gilead Sciences worth $505K as of Q2 2026.
Aristotle Atlantic Partners left its Gilead Sciences share count unchanged in Q2 2026.
Gilead Sciences made up 0.02% of Aristotle Atlantic Partners's portfolio in Q2 2026, its #104 holding.
Aristotle Atlantic Partners first reported a position in Gilead Sciences in Q4 2017 and has held it in 17 quarters since.
Aristotle Atlantic Partners's Gilead Sciences position peaked at $7.28M in Q1 2018.
2,268 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Aristotle Atlantic Partners's 13F filing for Q2 2026, filed 14 Aug 2026.